| Date | Quarter | Session | EPS (est → actual) | Revenue (est → actual) |
|---|---|---|---|---|
| Nov 23, 2026Next | Q4 2026 | After market close | 1.76 | 2.02 B |
Sep 2, 2026
Agilent is rebounding in life science tools with strong recurring revenue and stabilizing margins, but DCF flags overvaluation. Read more on A stock here.
Sep 1, 2026
SANTA CLARA, Calif., September 01, 2026--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fourier transform infrared (FTIR) analysis. Combining robust engineering, superior performance, and intuitive usability, the Cary 635 FTIR provides laboratories with a powerful solution that enhances reliability, boosts productivity, and delivers the versatility required for today’s analytical chal
Aug 31, 2026
Pharma revenue surged 12% while advanced therapeutics grew nearly 30%, beating guidance.
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Aug 29, 2026
Agilent Technologies, Inc. (NYSE:A) delivered fiscal third-quarter revenue of $1.88 billion, an increase of 8.1% from a year earlier. Core revenue, which excludes currency movements and recent acquisitions and divestitures, grew 7.3%. The company-defined non-GAAP operating margin of Agilent Technologies, Inc. (NYSE:A) reached 28.3%, expanding 320 basis points year over year. Approximately 110 basis points […]
Aug 28, 2026
Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88 billion. Guidance for next quarter’s revenue was better than expected at $1.99 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $1.62 per share was 9% above analysts’ consensus estimates.
Agilent Technologies (A) is back in focus after raising its fiscal 2026 revenue guidance to a range of $7.49b to $7.51b, alongside fresh fourth quarter projections tied to its latest earnings release. The raised 2026 guidance and stronger recent quarters have come alongside a clear shift in how the market is pricing Agilent Technologies, with a 30 day share price return of 12.20% and a 1 year total shareholder return of 27.21%, which points to building momentum rather than fading...
Aug 27, 2026
Earlier this week, Agilent Technologies reported third-quarter fiscal 2026 results showing higher sales and earnings year on year, and raised its full-year 2026 revenue guidance to US$7.49 billion–US$7.51 billion alongside issuing fourth-quarter revenue guidance of US$1.98 billion–US$2.00 billion. Management pointed to strong demand in pharma, China, and applied markets, plus efficiency gains from its Ignite program, as key drivers behind the improved outlook and margin expansion. We’ll now...
Stifel analyst Daniel Arias maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $170 to $180.
Citigroup analyst Patrick Donnelly maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $185 to $190.
JP Morgan analyst Casey Woodring maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $180 to $190.
Moby summary of Agilent Technologies, Inc.'s Q3 2026 earnings call
TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $155 to $180.
Agilent Technologies Inc (NYSE:A) delivered third-quarter earnings and revenue ahead of analyst forecasts and raised its fiscal 2026 guidance, supported by improving end markets and healthy demand for its laboratory technologies. Shares gained more than 3% in premarket trading on Thursday following the update.
Bernstein analyst Eve Burstein maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $155 to $180.
RBC Capital analyst Dan Leonard maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $155 to $185.
Agilent (A) stock is upgraded to Buy after strong Q3 2026 results; see revenue/EPS growth, margin gains, FY26 outlook, and valuation discount. See more here.
Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies (NYSE:A) with a Outperform and raises the price target from $148 to $172.
Agilent Technologies Inc (A) reports 7.3% core revenue growth and raises full-year EPS outlook, driven by robust pharma and China performance.
2026-08-27. The following slide deck was published by Agilent Technologies, Inc.
Agilent Technologies (NYSE:A) reported third-quarter fiscal 2026 revenue of $1.88 billion, with core revenue growth of 7.3%, exceeding the high end of its guidance range. The company said earnings per share were $1.56 excluding tariff-refund benefits, up 14% from a year earlier and $0.06 above the t
Aug 26, 2026
The headline numbers for Agilent (A) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilent (A) delivered earnings and revenue surprises of +9.46% and +2.08%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Life sciences tools company Agilent Technologies (NYSE:A) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.1% year on year to $1.88 billion. Guidance for next quarter’s revenue was better than expected at $1.99 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $1.62 per share was 9% above analysts’ consensus estimates.
Investing.com -- Agilent Technologies Inc (NYSE:A) reported third-quarter results that topped analyst expectations and raised its full-year guidance, driven by improving end markets and strong product demand. Shares rose more than 3% in premarket trading Thursday.
SANTA CLARA, Calif., August 26, 2026--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core(1) compared with the third quarter of fiscal year 2025.
